Advisor Website Home | Contact Us | Site Map | Help | Career Opportunities

Detailed Fund Information

The New Economy Fund® (growth fund)

Class C shares

Select a fund and share class

How do the share classes differ?

Daily Prices

Updated April 23, 2014, 3:16PM Pacific time

Net Asset Value (NAV) $35.89
NAV Change $−0.16
Maximum Offering Price (MOP) $35.89

(All prices are subject to revision.)

Historical Prices & Distributions

Choose a date

Ticker Symbols & Fund Numbers

Fund Number 314
Ticker/Quotron Symbol ANFCX
CUSIP Number 643822 30 7

Fund Description

Fund Objective The investment objective of the fund is long-term growth of capital. Current income is a secondary consideration.
Distinguishing Characteristics Invests in securities of companies that can benefit from innovation, exploit new technologies or provide products and services that meet the demands of an evolving global economy.
Types of Investments Invests primarily in common and preferred stocks, securities convertible into common stocks, and cash and equivalents.
Non-U.S. Holdings May invest up to 45% of assets in securities of companies domiciled outside the U.S.

Fund Facts

Minimum Initial Investment $250
Shareholder Accounts (aggregated for all share classes; updated monthly) 753,066
Regular Dividends Paid December
Capital Gains Paid December
Fund Inception December 1, 1983
Fiscal Year-End November

The months indicated for dividends and capital gains paid represent the anticipated current year ex-dividend date schedule for all share classes.

Returns & Expenses

Figures shown are past results and are not predictive of results in future periods. Current and future results may be lower or higher than those shown. Results shown at net asset value have all distributions reinvested. If a sales charge had been deducted, the results would have been lower. Share price and return will vary, so investors may lose money. Investing for short periods makes losses more likely. Investments are not FDIC-insured, nor are they deposits of or guaranteed by a bank or any other entity, so they may lose value. Returns with sales charge for Class C shares reflect the deduction of a contingent deferred sales charge (1%) on shares sold within the first year of purchase. Definitions and other important legal information about these prices and returns are shown below.

Rates of Return*

  Average Annual Total Returns
1 yr 3 yrs 5 yrs 10 yrs Fund Lifetime
March 31, 2014 (most recent month-end)
NAV 29.88% 16.53% 22.65% 8.81% 11.23%
With CDSC 28.88% 16.53% 22.65% 8.81% 11.23%
March 31, 2014 (most recent quarter-end)
NAV 29.88% 16.53% 22.65% 8.81% 11.23%
With CDSC 28.88% 16.53% 22.65% 8.81% 11.23%

Expense Ratios

The New Economy Fund 1.63%
Lipper Growth Funds Average 1.92%

12-Month Distribution Rates

As of March 31, 2014 (updated monthly)

NAV 0.00%

Annualized 30-Day SEC Yield

As of March 31, 2014 (updated monthly)

At net asset value −0.50%


Largest Industry Holdings

% of net assets as of March 31, 2014 (updated quarterly)

Biotechnology 9.7%
Banks 6.3%
Media 5.7%
Hotels, restaurants & leisure 5.4%
Internet software & services 5.0%
Health care equipment & supplies 4.7%
Software 3.8%
Semiconductors & semiconductor equipment 3.8%
Life sciences tools & services 3.2%
Internet & catalog retail 3.1%

Portfolio Holdings

(updated quarterly, upon availability)

Asset Mix

as of March 31, 2014 (updated monthly)

U.S. Equities 54.9%
Non-U.S. Equities 33.5%
Cash & Equivalents 11.6%

Geographic Breakdown

% of net assets as of March 31, 2014 (updated quarterly)

United States 54.9%
Europe 16.2%
Asia & Pacific Basin 16.4%
Other (Including Canada & Latin America) 0.9%
Cash & equivalents 11.6%

Assets and Portfolio Turnover (for fiscal years)

Fiscal Year Fund Assets (billions) Portfolio Turnover
2013 $12.4 29%
2012 $7.8 37%
2011 $6.8 45%
2010 $7.3 47%
2009 $7.1 51%

Assets shown are for combined share classes.

Largest Equity Holdings

Percent of net assets as of March 31, 2014 (updated monthly)



Internet subscription service for watching TV shows and movies.


Gilead Sciences

Develops drugs to treat infectious diseases and cancer.


Thermo Fisher Scientific

A leading worldwide provider of analytical instruments, including lab and industrial equipment.



One of the most frequently used website search engines in the world.


Galaxy Entertainment Group

Operator of gaming and entertainment facilities in Macau and a manufacturer of construction materials.


Alexion Pharmaceuticals

Biopharmaceutical company focused on treating severe and ultra-rare disorders.


Samsung Electronics

Korea's top electronics manufacturer and a global leader in semiconductor production.



Global manufacturer of health care products, specializing in hemoderivatives.


Nielsen Holdings

Marketing and advertisement measurement company.


lululemon athletica

Manufacturer and retailer of yoga-inspired athletic apparel.


Portfolio Managers

Number of years with American Funds or affiliates
Timothy D. Armour 31
Mark E. Denning 32
Claudia P. Huntington 39
Harold H. La 15

(as of the prospectus dated February 1, 2014)

The portfolio managers shown are reflected in the fund’s most recent prospectus.

Important Legal Information

Investing outside the United States involves risks, such as currency fluctuations, periods of illiquidity and price volatility, as more fully described in the prospectus. These risks may be heightened in connection with investments in developing countries.

* Investment results assume all distributions are reinvested and reflect applicable fees and expenses. Class C shares were first offered on March 15, 2001. Class C share results prior to the date of first sale are hypothetical based on Class A share results without a sales charge, adjusted for estimated additional annual expenses. Class C shares convert to Class F-1 shares after 10 years. View dates of first sale and specific expense adjustment information for Class C shares.

  When applicable, investment results reflect fee waivers and/or expense reimbursements, without which results would have been lower. Read details about how waivers and/or reimbursements affect the results for each fund.

Source for Lipper expense ratio comparison: Lipper, based on level-load funds, excluding funds of funds, for the most recent fiscal year-ends available as of March 31, 2014. The fund’s expense ratio is as of the fund’s prospectus. The expense ratios do not reflect sales charges.

The SEC yield reflects the rate at which the fund is earning income on its current portfolio of securities, while the distribution rate reflects the fund's past dividends paid to shareholders. Accordingly, the fund's SEC yield and distribution rate may differ.

Investors should carefully consider investment objectives, risks, charges and expenses. This and other important information is contained in the fund prospectuses, summary prospectuses and CollegeAmerica Program Description, which can be obtained from a financial professional and should be read carefully before investing. CollegeAmerica is distributed by American Funds Distributors® and sold through unaffiliated intermediaries.